Search results for "AstraZeneca"

Showing 1 - 4 of 4 results

Sort results by: date | relevance

Search filters:

By Date

  • 1999 Remove filter

Click remove filters icon to remove filters

Clear this search

Add Search Filters:

By Date

By Publication

By News Type

By Discipline

FOCUS: HEALTHCARE PR - A new pill to swallow. A further layer of healthcare regulation will necessitate greater levels of pre-launch PR for new drugs. Nick Purdom reports

10 Dec 1999 | by NICK PURDOM

AstraZeneca chief executive Tom McKillop, who told Tony Blair the Relenza judgment had potentially ...

INTERNATIONAL: AstraZeneca hires H&K for corporate citizenship push

10 Sep 1999 | by SOPHIE BARKER

ATHENS: Top three pharmaceuticals firm AstraZeneca has selected Hill and Knowlton as its first...ATHENS: Top three pharmaceuticals firm AstraZeneca has selected Hill and Knowlton as its first ...

FOCUS: HEALTH PR - Top drug brands face a bitter pill/What happens to popular brand name drugs, such as Prozac, when their patents run out and the generic competitors move in? Nick Purdom reports

03 Sep 1999 | by NICK PURDOM

. For manufacturers this has serious implications. In the UK, for example, 47 per cent of AstraZeneca s...AstraZeneca s drug sales come from two products - Zestril and Losec - both of which go off patent in 2002 ...

TOP 50 HEALTHCARE PR: Health complex - An increasing consumer awareness of health matters has created a diverse audience for healthcare PR, says Robert Gray

23 Jul 1999 | by ROBERT GRAY

Procter and Gamble. The consultancy also picked up work from new clients AstraZeneca, Janssen ...

 

Additional Information


Part of the Brand Republic Group